FDA Approves Suzetrigine: A Breakthrough Non-Opioid Painkiller for Acute Pain

FDA Approves Suzetrigine: A Breakthrough Non-Opioid Painkiller for Acute Pain By Francis Akenami, PhD, Department of Mental Health and Neuroscience, ThinkCzar LLC, Hillside New Jersey USA. On January 30, 2025, the U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine)…